These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 29288743)

  • 21. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
    Yu X; Huang Y; Collin-Osdoby P; Osdoby P
    J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CXCL12/CXCR4 signaling in malignant brain tumors: a potential pharmacological therapeutic target.
    Terasaki M; Sugita Y; Arakawa F; Okada Y; Ohshima K; Shigemori M
    Brain Tumor Pathol; 2011 Apr; 28(2):89-97. PubMed ID: 21210239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of chemokine receptor CXCR4 in monomeric and dimeric state with its endogenous ligand CXCL12: coarse-grained simulations identify differences.
    Cutolo P; Basdevant N; Bernadat G; Bachelerie F; Ha-Duong T
    J Biomol Struct Dyn; 2017 Feb; 35(2):399-412. PubMed ID: 26813575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The CXCR4/SDF-1 chemokine receptor axis: a new target therapeutic for non-small cell lung cancer.
    Otsuka S; Bebb G
    J Thorac Oncol; 2008 Dec; 3(12):1379-83. PubMed ID: 19057260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of cDNA and genomic sequences encoding a canine chemokine receptor, CXCR4 and its ligand CXCL12.
    Tsuchida S; Kagi A; Takahashi T
    Vet Immunol Immunopathol; 2007 Apr; 116(3-4):219-25. PubMed ID: 17316828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical relevance of chemokine receptor CXCR4].
    Gębura K; Bogunia-Kubik K
    Postepy Hig Med Dosw (Online); 2012 May; 66():252-66. PubMed ID: 22706111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract.
    Tachibana K; Hirota S; Iizasa H; Yoshida H; Kawabata K; Kataoka Y; Kitamura Y; Matsushima K; Yoshida N; Nishikawa S; Kishimoto T; Nagasawa T
    Nature; 1998 Jun; 393(6685):591-4. PubMed ID: 9634237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics of CXCL12 binding to atypical chemokine receptor 3 reveal a role for the receptor N terminus in chemokine binding.
    Gustavsson M; Dyer DP; Zhao C; Handel TM
    Sci Signal; 2019 Sep; 12(598):. PubMed ID: 31506383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyfunctionality of the CXCR4/CXCL12 axis in health and disease: Implications for therapeutic interventions in cancer and immune-mediated diseases.
    Britton C; Poznansky MC; Reeves P
    FASEB J; 2021 Apr; 35(4):e21260. PubMed ID: 33715207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The axis of evil in the fight against cancer.
    Petrushev B; Tomuleasa C; Suşman S; Sorişău O; Aldea M; Kacsó G; Buigă R; Irimie A
    Rom J Intern Med; 2011; 49(4):319-25. PubMed ID: 22568277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The peculiarities of the SDF-1/CXCL12 system: in some cells, CXCR4 and CXCR7 sing solos, in others, they sing duets.
    Puchert M; Engele J
    Cell Tissue Res; 2014 Feb; 355(2):239-53. PubMed ID: 24292718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential of CXCR4 antagonists for the treatment of metastatic lung cancer.
    Burger JA; Stewart DJ; Wald O; Peled A
    Expert Rev Anticancer Ther; 2011 Apr; 11(4):621-30. PubMed ID: 21504328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural basis of the interaction between chemokine stromal cell-derived factor-1/CXCL12 and its G-protein-coupled receptor CXCR4.
    Kofuku Y; Yoshiura C; Ueda T; Terasawa H; Hirai T; Tominaga S; Hirose M; Maeda Y; Takahashi H; Terashima Y; Matsushima K; Shimada I
    J Biol Chem; 2009 Dec; 284(50):35240-50. PubMed ID: 19837984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetically manipulated progenitor/stem cells restore function to the infarcted heart via the SDF-1α/CXCR4 signaling pathway.
    Wang Y; Luther K
    Prog Mol Biol Transl Sci; 2012; 111():265-84. PubMed ID: 22917235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cloning and characterizing mutated human stromal cell-derived factor-1 (SDF-1): C-terminal alpha-helix of SDF-1alpha plays a critical role in CXCR4 activation and signaling, but not in CXCR4 binding affinity.
    Tan Y; Du J; Cai S; Li X; Ma W; Guo Z; Chen H; Huang Z; Xiao J; Cai L; Cai S
    Exp Hematol; 2006 Nov; 34(11):1553-62. PubMed ID: 17046575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CXCR4/CXCL12 axis in non small cell lung cancer (NSCLC) pathologic roles and therapeutic potential.
    Wald O; Shapira OM; Izhar U
    Theranostics; 2013; 3(1):26-33. PubMed ID: 23382783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional and structural consequences of chemokine (C-X-C motif) receptor 4 activation with cognate and non-cognate agonists.
    Eby JM; Abdelkarim H; Albee LJ; Tripathi A; Gao X; Volkman BF; Gaponenko V; Majetschak M
    Mol Cell Biochem; 2017 Oct; 434(1-2):143-151. PubMed ID: 28455789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXCL14 antagonizes the CXCL12-CXCR4 signaling axis.
    Hara T; Tanegashima K
    Biomol Concepts; 2014 May; 5(2):167-73. PubMed ID: 25372750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells.
    Lee BC; Lee TH; Avraham S; Avraham HK
    Mol Cancer Res; 2004 Jun; 2(6):327-38. PubMed ID: 15235108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A New Anti-CXCR4 Antibody That Blocks the CXCR4/SDF-1 Axis and Mobilizes Effector Cells.
    Broussas M; Boute N; Akla B; Berger S; Beau-Larvor C; Champion T; Robert A; Beck A; Haeuw JF; Goetsch L; Bailly C; Dumontet C; Matthes T; Corvaia N; Klinguer-Hamour C
    Mol Cancer Ther; 2016 Aug; 15(8):1890-9. PubMed ID: 27297868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.